# Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

Study · id `cardio:ct-nct06440694` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06440694](<https://clinicaltrials.gov/study/NCT06440694>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06440694

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06440694. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-07 (actual); primary completion 2027-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06440694, source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)
- Started: 2025-07-07 (actual) (ClinicalTrials.gov record NCT06440694, source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)
- Primary completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT06440694, source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT06440694, source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)
- Countries: Canada (ClinicalTrials.gov record NCT06440694, source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06440694-2026-07-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
- Condition: Venous Thromboembolism
- Intervention (Drug): Colchicine 0.5 mg po
- Intervention (Drug): Placebo 0.5 mg po
- Lead sponsor: Ottawa Hospital Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: Ottawa Hospital Research Institute (`cardio:org-ottawa-hospital-research-institute`)

## Provenance

Content hash: 831a38f90910019da0df93d0d9a5adec0a16650c8936eee020aa34b7ec210453
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
